A Study on Efficacy and Safety of HST101 in Chinese Patients with Hypercholesterolemia

Clinical trial NCT06568471 · RECRUITING

Trial details

NCT number: NCT06568471
Sponsor: Hasten Biopharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Hypercholesterolemia Dyslipidemias Primary Hypercholesterolemia Heterozygous Familial Hypercholesterolemia Hyperlipidemia; Mixed Metabolic Disease ASCVD

Start date: 2024-11-16
Primary completion: 2026-02-01
Enrollment: 210

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.